VRAYQ — Viewray Share News
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $0.00m
- -$3.53m
- $102.21m
Brief: Viewray Announces Fourth Quarter And Full Year 2022 Results
ViewRay Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: ViewRay Enters Into Cooperation Agreement With Hudson Executive Capital
Brief: Viewray Appoints William P. "Bill" Burke As Chief Financial Officer
U.S. STOCKS ON THE MOVE-Lamb Weston Foldings, Stitch Fix, Bellerophon Therapeutics
ViewRay rises on purchase agreements for radiation therapy system
Brief: University Hospitals In Cleveland Enters Into Master Purchase Agreement With Viewray
Brief: ViewRay Expands Access To Non-Dilutive Capital With New Debt Facility
ViewRay Inc reports results for the quarter ended in September - Earnings Summary
Brief: Viewray Announces Third Quarter 2022 Results
ViewRay Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Mirage Phase Iii Randomized Controlled Trial Demonstrates Superiority Of Mridian® Mri-Guidance In Stereotactic Body Radiotherapy (Sbrt) For Localized Prostate Cancer
U.S. STOCKS ON THE MOVE-TransDigm, Vaxcyte, Tricida
Brief: Viewray Announces Primary Endpoint Outcome From First Prospective, Multi-Institutional Study To Deliver Ablative Doses Of Radiation To Pancreatic Cancer Patients
ViewRay up as pancreatic cancer trial meets primary goal
Brief: ViewRay Launches Phase Iii Pancreatic Cancer Study To Demonstrate Superior Overall Survival For Patients Receiving Mri-Guided Ablative Radiation Therapy
Brief: Genesiscare Purchases Two Additional ViewRay Mridian Mri-Guided Radiotherapy Systems For Guildford And Birmingham Projects, Doubling United Kingdom Footprint To Four Systems
U.S. STOCKS ON THE MOVE-Pinterest, Aemetis, Walmart
U.S. STOCKS ON THE MOVE-Twitter, ChargePoint, IMAX